Viewing nowCombinationExmet XR Sustained Release Tablet 100/1000 Milligrams
Sitagliptin Hydrochloride Hydrate 113.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.

MFDS item code 202202074 · Approved 2022.05.17 · Insurance code 671707140
Improvement of glycemic control in patients with type 2 diabetes mellitus
This drug is used to help patients with Type 2 diabetes control their blood sugar levels. When taken in conjunction with dietary and exercise therapy, it can more effectively manage blood sugar levels. It particularly contains a combination of sitagliptin and metformin, which helps prevent blood sugar rises and maintain balance. Consistent use can lead to improved blood sugar control, thus aiding in health maintenance. This drug is used for blood sugar control in Type 2 diabetes.
The dose of this medication for antidiabetic therapy should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: sitagliptin 100 mg and metformin 2000 mg. To reduce gastrointestinal adverse reactions caused by metformin, this medication should be taken with a meal once daily, preferably in the evening, with gradual dose escalation. Take one 100/1000 mg extended-release tablet once daily. Patients taking the 50/500 mg or 50/1000 mg extended-release tablets should take 2 tablets together once daily. 1. Patients not currently treated with metformin: For patients with no prior history of antidiabetic drug therapy who have difficulty achieving adequate glycemic control with monotherapy, or for whom adequate glycemic control cannot be achieved with sitagliptin monotherapy, the initial total daily dose of this medication is sitagliptin 100 mg and metformin 1000 mg. If adequate glycemic control cannot be achieved with the initial dose, the dose may be gradually increased up to the maximum recommended daily dose of metformin, 2000 mg, to reduce gastrointestinal adverse reactions caused by metformin. 2. Patients being treated with metformin: - The recommended initial total daily dose of this medication for patients who cannot achieve adequate glycemic control with metformin monotherapy is sitagliptin 100 mg and the patient's current metformin dose. - Patients switching from combination therapy with sitagliptin and metformin to this medication may start at their current doses of sitagliptin and metformin. - Patients taking immediate-release metformin at their current dose of 850 mg or 1000 mg twice daily may start with 2 tablets of this medication 50/1000 mg extended-release once daily. 3. Patients unable to achieve adequate glycemic control with combination therapy of metformin and a sulfonylurea, metformin and insulin, or metformin and a thiazolidinedione: The initial total daily dose of this medication is sitagliptin 100 mg. The initial dose of metformin should be based on the patient's blood glucose level and current dose. The dose should be gradually increased to reduce gastrointestinal adverse reactions caused by metformin. When this medication is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia induced by the sulfonylurea or insulin. Patients with renal impairment This medication may be used in patients with moderate renal impairment, stage 3a (creatinine clearance [CrCl] ≥ 45 and <60 mL/min or estimated glomerular filtration rate (eGFR) ≥ 45 and <60 mL/min/1.73m2), who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. Since the starting dose of metformin is 500 mg or 850 mg once daily, treatment should not be initiated with this medication. The maximum recommended dose of metformin is 1000 mg daily. Renal function should be monitored carefully every 3-6 months. If renal function declines to CrCl <45 mL/min or eGFR <45 mL/min/1.73m2, this medication should be discontinued immediately.
This drug contains the ingredients sitagliptin and metformin and is used for diabetes treatment. First, caution should be taken for allergic reactions when taking this medication. Rarely, anaphylaxis, angioedema, and severe skin diseases may occur, so if any unusual symptoms appear, discontinue use immediately and consult your doctor. Acute pancreatitis has also been reported, so if symptoms such as abdominal pain or vomiting occur during treatment, notify healthcare professionals immediately. The metformin component can cause lactic acidosis, a serious side effect, so patients with impaired kidney function or liver dysfunction should not take this drug. In particular, patients with moderate to severe kidney dysfunction, acute heart failure, myocardial infarction, severe infections, and women who are pregnant or breastfeeding should refrain from using this medication. There are also patients for whom this drug must be administered cautiously. For instance, if you have irregular eating habits or suddenly increase physical activity, or if you are taking other medications, be aware that the risk of hypoglycemia or lactic acidosis may increase. While taking this medication, pay attention to symptoms of hypoglycemia, especially when combined with other antihyperglycemic agents like insulin or sulfonylureas, as the risk of hypoglycemia may increase; therefore, blood sugar levels should be checked frequently. In addition, this drug requires regular monitoring of liver and kidney function. There could be a risk of Vitamin B12 deficiency, hence regular blood tests are necessary. Excessive drinking should be avoided during treatment, as it may increase the risk of side effects from this drug. Before undergoing surgery or tests using radiographic contrast agents, temporarily discontinue this medication, and after confirming normal kidney function post-test, resume treatment. Finally, safety for children under 18 years of age and for pregnant or breastfeeding women has not been established, thus it is advisable not to use this drug in those groups. Please adhere to the precautions outlined above during treatment and consult healthcare professionals immediately if you experience any unusual symptoms for safe treatment.
Not everyone experiences these, and they can vary from person to person.
This drug may be sensitive to air and moisture, so it should be stored in a tightly closed container. It is recommended to maintain storage temperatures between 1 degree and 30 degrees Celsius at room temperature. Proper storage will help to maintain the drug's effectiveness and safety for a longer period.
Bright blue, oval-shaped sustained-release film-coated tablet that is convex on both sides
28 tablets/bottle, 56 tablets/bottle, 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationSitagliptin Hydrochloride Hydrate 113.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Shinil Pharmaceutical Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 113.4mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationSitagliptin Hydrochloride Hydrate 56.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Korea Hutech Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.